These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21222326)

  • 1. [Professor Bertram Pitt on therapy of heart failure after EMPHASIS. "Clear prognosis improvement" (interview by Dr. Med. Dirk Enecke)].
    Pitt B
    MMW Fortschr Med; 2010 Dec; 152(48):13. PubMed ID: 21222326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
    MMW Fortschr Med; 2010 Dec; 152(48):12-3. PubMed ID: 21226226
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antialdosteronic therapy in mild chronic heart failure: from AREA IN-CHF to EMPHASIS-HF].
    Boccanelli A
    Recenti Prog Med; 2010 Oct; 101(10):402-5. PubMed ID: 21137577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The aldosterone antagonist spironolactone prolongs the survival of chronic heart failure patients. The results of the RALES study. The Randomized Aldactone Evaluation Study].
    Schwinger RH
    Dtsch Med Wochenschr; 1999 Aug; 124(34-35):987-8. PubMed ID: 10488324
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of diuretics and aldosterone antagonists in the treatment of heart failure].
    Schwinger RH
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S40-7. PubMed ID: 10535046
    [No Abstract]   [Full Text] [Related]  

  • 6. Aldosterone antagonists in congestive heart failure.
    Soberman J; Chafin CC; Weber KT
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1024-8. PubMed ID: 12186262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone receptor antagonism and heart failure: insights from an outpatient clinic.
    Mariotti R; Borelli G; Coceani M; Zingaro S; Barison A; Morelli I; Rondinini L
    J Clin Pharm Ther; 2008 Aug; 33(4):349-56. PubMed ID: 18613852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Finely adjusted differential therapy succeeds this way! References for dose adjustments in heart failure (interview by Dr. Dirk Einecke)].
    Erdmann E
    MMW Fortschr Med; 2005 Sep; 147(39):11. PubMed ID: 16245770
    [No Abstract]   [Full Text] [Related]  

  • 10. [New evidence for the usefulness of an old drug in the treatment of heart failure].
    Oseguera Moguel J
    Rev Invest Clin; 2000; 52(1):14-6. PubMed ID: 10818804
    [No Abstract]   [Full Text] [Related]  

  • 11. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 12. Spironolactone for congestive heart failure.
    Lindbloom EJ; Koenig CJ
    J Fam Pract; 1999 Oct; 48(10):752. PubMed ID: 12224671
    [No Abstract]   [Full Text] [Related]  

  • 13. Aldosterone blockade in patients with heart failure and a reduced left ventricular ejection fraction.
    Pitt B
    Eur Heart J; 2009 Feb; 30(4):387-8. PubMed ID: 19190013
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy of systolic heart failure: emphasis on mortality outcomes.
    Barbour MM; Zuwallack A
    Med Health R I; 2001 Feb; 84(2):55-8. PubMed ID: 11272661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic heart failure: improvement of the prognosis by therapy?].
    Drexler H
    Herz; 1990 Jun; 15(3):214-21. PubMed ID: 1973916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-aldosterone therapy in severe heart failure].
    van Guldener C; Donker AJ
    Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1724-6. PubMed ID: 10494316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systolic heart failure in the elderly].
    Kilter H; Böhm M
    Dtsch Med Wochenschr; 2005 Mar; 130(12):698-703. PubMed ID: 15776354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone antagonists - revisited.
    Sathyamurthy I; Jayanthi K
    J Assoc Physicians India; 2001 Sep; 49():904-6. PubMed ID: 11837759
    [No Abstract]   [Full Text] [Related]  

  • 19. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure.
    Masoudi FA; Havranek EP; Wolfe P; Gross CP; Rathore SS; Steiner JF; Ordin DL; Krumholz HM
    Am Heart J; 2003 Aug; 146(2):250-7. PubMed ID: 12891192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of angiotensin receptor antagonists on mortality and morbidity in heart failure--and an interaction with beta blockade.
    Coats AJ
    Int J Cardiol; 2001 Jan; 77(1):1-4. PubMed ID: 11150619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.